Estrogen-related receptor α as a therapeutic target in cancer

Endocrine-Related Cancer

Volumn 13, Issue SUPPL. 1, 2006, Pages

  Stein, R A ^a   McDonnell, D P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIESTROGEN; AROMATASE INHIBITOR; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA; ESTROGEN RELATED RECEPTOR ALPHA ANTAGONIST; ESTROGEN RELATED RECEPTOR BETA; ESTROGEN RELATED RECEPTOR GAMMA; INDOLE DERIVATIVE; PYRAZOLE DERIVATIVE; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

BREAST CANCER; CANCER GROWTH; CONFERENCE PAPER; DRUG TARGETING; FEMALE; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; NONHUMAN; OSTEOPOROSIS; OVARY CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE AND BONES; ENERGY METABOLISM; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; RECEPTOR CROSS-TALK; RECEPTORS, ESTROGEN;

EID: 33846876099     PISSN: 13510088     EISSN: None     Source Type: Journal    
DOI: 10.1677/erc.1.01292     Document Type: Conference Paper

References (58)

1. Apak TI & Duffel MW 2004 Interactions of the stereoisomers of alpha-hydroxytamoxifen with human hydroxysteroid sulfotransferase SULT2A1 and rat hydroxysteroid sulfotransferase STA. Drug Metabolism and Disposition 32 1501-1508.
2. Ariazi EA, Clark GM & Mertz JE 2002 Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Research 62 6510-6518.
3. Barry JB & Giguere V 2005 Epidermal growth factor-induced signaling in breast cancer cells results in selective target gene activation by orphan nuclear receptor estrogen-related receptor alpha. Cancer Research 65 6120-6129.
4. Bonnelye E & Aubin JE 2005 Estrogen receptor-related receptor alpha: a mediator of estrogen response in bone. Journal of Clinical Endocrinology and Metabolism 90 3115-3121.
5. Bonnelye E, Meerdad L & Aubin JE 2001 The orphan receptor, estrogen related receptor ERR alpha, is highly expressed in osteoblasts and is required for bone formation. Bone 28 S87.
6. Bonnelye E, Kung V, Laplace C, Galson DL & Aubin JE 2002 Estrogen receptor-related receptor alpha impinges on the estrogen axis in bone: potential function in osteoporosis. Endocrinology 143 3658-3670.
7. Bookout A & Mangelsdorf D 2006 Anatomical profiling of nuclear receptor expression reveals a hierarchical transcriptional network. Cell 126 789-799.
8. Busch BB, Stevens WC, Martin R, Ordentlich P, Zhou S, Sapp DW, Horlick RA & Mohan R 2004 Identification of a selective inverse agonist for the orphan nuclear receptor estrogen-related receptor alpha. Journal of Medicinal Chemistry 47 5593-5596.
9. Chen S, Zhou DJ, Yang C & Sherman M 2001 Molecular basis for the constitutive activity of estrogen-related receptor alpha-1. Journal of Biological Chemistry 276 28465-28470.
10. Clinton GM & Hua W 1997 Estrogen action in human ovarian cancer. Critical Reviews in Oncology Hematology 25 1.
11. Cornish J, Callon KE, Naot D, Palmano KP, Banovic T, Bava U, Watson M, Lin JM, Tong PC, Chen Q et al. 2004 Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivo. Endocrinology 145 4366-4374.
12. Coward P, Lee D, Hull MV, Lehmann JM4-Hydroxyt & Lehmann JM 2001 4-Hydroxytamoxifen binds to and deactivates the estrogen-related receptor gamma. PNAS 98 8880-8884.
13. Cui Y, Parra I, Zhang M, Hilsenbeck SG, Tsimelzon A, Furukawa T, Horii A, Zhang Z-Y, Nicholson RI & Fuqua SAW 2006 Elevated expression of mitogen-activated protein kinase phosphatase 3 in breast tumors: a mechanism of tamoxifen resistance. Cancer Research 66 5950-5959.
14. Deuschle U, Heck S, Kober I, Bauer U & Balogh I. (Lion Bioscience AG) (2004). NR3B1 nuclear receptor-binding 3-substituted pyrazole derivatives, and therapeutic uses. EP001398029A8.
15. Eudy JD, Yao S, Weston MD, Ma-Edmonds M, Talmadge CB, Cheng JJ, Kimberling WJ & Sumegi J 1998 Isolation of a gene encoding a novel member of the nuclear receptor superfamily from the critical region of Usher syndrome type IIa at 1q41. Genomics 50 382-384.
16. Felson DT, Zhang Y, Hannan MT, Kiel DP, Wilson PWF & Anderson JJ 1993 The effect of postmenopausal estrogen therapy on bone density in elderly women. New England Journal of Medicine 329 1141-1146.
17. Giguere V 2002 To ERR in the estrogen pathway. Trends In Endocrinology And Metabolism 13 220-225.
18. Giguere V, Yang N, Segui P & Evans RM 1988 Identification of a new class of steroid hormone receptors. Nature 331 91-94.
19. Greschik H, Wurtz J-M, Sanglier S, Bourguet W, Dorsselaer AV, Moras D & Renaud JP 2002 Structural and functional evidence for ligand-independent transcriptional activation by the estrogen-related receptor 3. Molecular Cell 9 303-313.
20. Greschik H, Flaig R, Renaud JP & Moras D 2004 Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity. Journal of Biological Chemistry 279 33639-33646.
21. Huss JM, Torra IP, Staels B, Giguere V & Kelly DP 2004 Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor at signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle. Molecular and Cellular Biology 24 9079-9091.
22. Kallen J, Schlaeppi JM, Bitsch F, Filipuzzi I, Schilb A, Riou V, Graham A, Strauss A, Geiser M & Fournier B 2004 Evidence for ligand-independent transcriptional activation of the human estrogen-related receptor alpha (ERR alpha) - Crystal structure of ERR alpha ligand binding domain in complex with peroxisome proliferator-activated receptor coactivator-1 alpha. Journal of Biological Chemistry 279 49330-49337.
23. Kamei Y, Lwin H, Saito K, Yokoyama T, Yoshiike N, Ezaki O & Tanaka H 2005 The 2.3 genotype of ESRRA23 of the ERR alpha gene is associated with a higher BMI than the 2.2 genotype. Obesity Research 13 1843-1844.
24. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E & Kawashima H 1995 Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270 1491-1494.
25. Kelley DE, He J, Menshikova EV & Ritov VB 2002 Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51 2944-2950.
26. Kraus RJ, Ariazi EA, Farrell ML & Mertz JE 2002 Estrogen-related receptor alpha 1 actively antagonizes estrogen receptor-regulated transcription in MCF-7 mammary cells. Journal of Biological Chemistry 277 24826-24834.
27. Laflamme N, Giroux S, Loredo-Osti JC, Elfassihi L, Dodin S, Blanchet C, Morgan K, Giguere V & Rousseau F 2005 A frequent regulatory variant of the estrogen-related receptor alpha gene associated with BMD in French-Canadian premenopausal women. Journal of Bone Mineral Research 20 938-944.
28. Laudet V 1997 Evolution of the nuclear receptor superfamily: early diversification from an ancestral orphan receptor. Journal of Molecular Endocrinology 19 207-226.
29. Laudet V, Hänni C, Coll J, Catzeflis F & Stéhelin D 1992 Evolution of the nuclear receptor gene superfamily. EMBO Journal 11 1003-1013.
30. Lin J, Tarr PT, Yang R, Rhee J, Puigserver P, Newgard CB & Spiegelman BM 2003 PGC-1beta in the regulation of hepatic glucose and energy metabolism. Journal of Biological Chemistry 278 30843-30848.
31. Lin J, Yang R, Tarr PT, Wu P-H, Handschin C, Li S, Yang W, Pei L, Uldry M, Tontonoz P et al. 2005 Hyperlipidemic effects of dietary saturated fats mediated through PGC-1 beta coactivation of SREBP. Cell 120 261-273.
32. Lowell BB & Shulman GI 2005 Mitochondrial dysfunction and type 2 diabetes. Science 307 384-387.
33. Lu D, Kiriyama Y, Lee KY & Giguere V 2001 Transcriptional regulation of the estrogen-inducible pS2 breast cancer marker gene by the ERR family of orphan nuclear receptors. Cancer Research 61 6755-6761.
34. Luo JM, Sladek R, Carrier J, Bader JA, Richard D & Giguere V 2003 Reduced fat mass in mice lacking orphan nuclear receptor estrogen-related receptor alpha. Molecular and Cellular Biology 23 7947-7956.
35. McKenna NJ, Lanz RB & O'Malley BW 1999 Nuclear receptor coregulators: cellular and molecular biology. Endocrine Reviews 20 321-344.
36. Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E et al. 2003 PGC-1 alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 34 267-273.
37. Mootha VK, Handschin C, Arlow D, Xie XH, Pierre J, St, Sihag S, Yang WL, Altshuler D, Puigserver P, Patterson N et al. 2004 ERR alpha and Gabpa/b specify PGC-1 alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle. PNAS 101 6570-6575.
38. Nolte RT, Wang L, Orband-Miller LA, Way JM, Martin JJ, Roa AM, Vela L, Miller AB, Willson TM & Zuercher WJ 2005 Identification and X-ray Crystal Structure of an ERR Alpha Inverse Agonist Reveals a New Mechanism of Nuclear Receptor Antagonism 230th American Chemical Society National Meeting, Washington, DC, USA 2005.
39. Oberkofler H, Linnemayr V, Weitgasser R, Klein K, Xie M, Iglseder B, Krempler F, Paulweber B & Patsch W 2004 Complex haplotypes of the PGC-1alpha gene are associated with carbohydrate metabolism and type 2 diabetes. Diabetes 53 1385-1393.
40. Player MR, Pottorf RS, Rentzeperis D & De D. (Johnson and Johnson) 2004 Use of estrogen related receptor-modulating aryl ethers. US. 2006014812.
41. Puigserver P & Spiegelman BM 2003 Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocrine Reviews 24 78-90.
42. Robertson JF, Cannon PM, Nicholson RI & Blamey RW 1996 Oestrogen and progesterone receptors as prognostic variables in hormonally treated breast cancer. International Journal of Biological Markers 11 29-35.
43. Seely J, Amigh KS, Suzuki T, Mayhew B, Sasano H, Giguere V, Laganiere J, Carr BR & Rainey WE 2005 Transcriptional regulation of dehydroepiandrosterone sulfotransferase (SULT2A1) by estrogen-related receptor alpha. Endocrinology 146 3605-3613.
44. Simpson ER 2003 Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 86 225-230.
45. Sladek R, Bader JA & Giguere V 1997 The orphan nuclear receptor estrogen-related receptor alpha is a transcriptional regulator of the human medium-chain acyl coenzyme A dehydrogenase gene. Molecular and Cellular Biology 17 5400-5409.
46. Suetsugi M, Su L, Karlsberg K, Yuan YC & Chen S 2003 Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Molecular Cancer Research 1 981-991.
47. Sun P, Sehouli J, Denkert C, Mustea A, Konsgen D, Koch I, Wei L & Lichtenegger W 2005 Expression of estrogen receptor-related receptors, a subfamily of orphan nuclear receptors, as new tumor biomarkers in ovarian cancer cells. Journal of Molecular Medicine 26 1699-1706.
48. Suzuki T, Miki Y, Moriya T, Shimada N, Ishida T, Hirakawa H, Ohuchi N & Sasano H 2004 Estrogen-related receptor alpha in human breast carcinoma as a potent prognostic factor. Cancer Research 64 4670-4676.
49. Tremblay GB, Bergeron D & Giguere V 2001 4-Hydroxytamoxifen is an isoform-specific inhibitor of orphan estrogen-receptor-related (ERR) nuclear receptors beta and gamma. Endocrinology 142 4572-4575.
50. Vanacker JM, Bonnelye E, Chopin-Delannoy S, Delmarre C, Cavailles V & Laudet V 1999a Transcriptional activities of the orphan nuclear receptor ERR alpha (estrogen receptor-related receptor-alpha). Molecular Endocrinology 13 764-773.
51. Vanacker JM, Pettersson K, Gustafsson JA & Laudet V 1999b Transcriptional targets shared by estrogen receptor-related receptors (ERRs) and estrogen receptor (ER) alpha, but not by ER beta. EMBO Journal 18 4270-4279.
52. Willy PJ, Murray IR, Qian J, Busch BB, Stevens WC, Martin R, Mohan R, Zhou SH, Ordentlich P, Wei P et al. 2004 Regulation of PPAR gamma coactivator 1 alpha (PGC-1 alpha) signaling by an estrogen-related receptor alpha (ERR alpha) ligand. PNAS 101 8912-8917.
53. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC et al. 1999 Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 98 115-124.
54. Xie W, Hong H, Yang NN, Lin RJ, Simon CM, Stallcup MR & Evans RM 1999 Constitutive activation of transcription and binding of coactivator by estrogen-related receptors 1 and 2. Molecular Endocrinology 13 2151-2162.
55. Yang C & Chen S 1999 Two organochlorine pesticides, toxaphene and chlordane, are antagonists for estrogen-related receptor alpha-1 orphan receptor. Cancer Research 59 4519-4524.
56. Yang C, Zhou DJ & Chen S 1998 Modulation of aromatase expression in the breast tissue by ERR alpha-1 orphan receptor. Cancer Research 58 5695-5700.
57. Yang NY, Shigeta H, Shi HP & Teng CT 1996 Estrogen-related receptor, hERR1, modulates estrogen receptor-mediated responses of human lactoferrin gene promoter. Journal of Biological Chemistry 271 5795-5804.
58. Yoon JC, Puigserver P, Chen G, Donovan J, Wu Z, Rhee J, Adelmant G, Stafford J, Khan CR, Granner DK et al. 2001 Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1. Nature 413 131-138.